1. Home
  2. SIDU vs FATE Comparison

SIDU vs FATE Comparison

Compare SIDU & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.62

Market Cap

105.1M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

115.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
FATE
Founded
2012
2007
Country
United States
United States
Employees
N/A
181
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.1M
115.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
SIDU
FATE
Price
$2.62
$0.98
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
47.3M
1.4M
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,623,538.00
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.66
52 Week High
$6.75
$1.99

Technical Indicators

Market Signals
Indicator
SIDU
FATE
Relative Strength Index (RSI) 69.25 37.81
Support Level $1.77 $0.98
Resistance Level $3.38 $1.12
Average True Range (ATR) 0.43 0.07
MACD 0.18 -0.01
Stochastic Oscillator 71.74 8.33

Price Performance

Historical Comparison
SIDU
FATE

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: